在非住院患者中药剂师服务的投资回报:范围审查
Armando Silva Almodovar1, Bella Blankenship2, Julia Miller2
1PharmPix Corporation, San Juan, PR, USA.
Research in social & administrative pharmacy : RSAP
|February 8, 2025
概括
药剂师 药剂师 药剂师 药剂师
科学领域:
- 卫生经济学 卫生经济学
- 药房实践 在药房实践.
- 研究成果 研究成果 研究成果
背景情况:
- 药剂师提供的药物管理服务的有限保险覆盖面阻碍了投资.
- 担心财务可行性和投资回报率 (ROI) 不清楚会影响付款人和雇主的决策.
- 随着药剂师角色的不断变化,需要进行强有力的经济评估.
研究的目的:
- 对非住院患者的药剂师驱动药物管理服务报告的ROI进行范围审查.
- 确定影响这些服务ROI分析的研究关键特征.
主要方法:
- 在PubMed,Embase和Web of Science进行了系统的文献搜索.
- 在Covidence,研究使用两阶段的过程进行了选.
- 包括的研究评估了非住院患者的药房服务,评估了成本影响,并报告了ROI.
主要成果:
- 审查中包括了28项研究.
- 报告的ROI差异很大,从-3%到504% (作为百分比),每美元花费1.29美元到18.5美元 (作为比率).
- 大多数研究报告了积极的投资回报率,但有五项没有指定计算方法,报告的一致性有限.
结论:
- 门诊医院的药剂师服务显示,对付款人和雇主来说,投资回报率在很大程度上是积极的.
- 对研究细节和经济结果的不一致报告可能会限制研究结果的概括性和有用性.
- 需要标准化报告,以支持更广泛地实施药剂师主导的服务.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...